Jørgensen, N. P., Zobek, N., Dreier, C., Haaber, J., Ingmer, H.
, Larsen, O. H. & Meyer, R. L. (2016).
Fibrinolytic drugs can reverse biofilm-associated resistance to in Staphylococcus aureus. Poster session presented at International Symposium on Staphylococci and Staphylococcus infectionsI, Seoul, Korea, Republic of.
Rodkjær, L. Ø., Laursen, T., Seeberg, K., Johansen, H., Drouin, M.
& Østergaard, L. J. (2016).
Fra offer til kriger - om at finde egne ressourcer og få balance i livet.. Poster session presented at Kunsten at kommunikere.
Ludvigsen, M., Vase, M. Ø., Bendix, K., Hamilton Dutoit, S. J., Rabinovich, G. A., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S. & D'Amore, F. A. (2016).
High Intratumoral Expression of Galectin-1 Correlated with Superior Outcome in HIV-associated DLBCL..
Hønge, B. L., Jespersen, S., Aunsborg, J., Candida, M., Té, D. D. S.
, Laursen, A. L., Østergaard, L. J., Erikstrup, C. & Wejse, C. (2016).
High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa.
Pan African Medical Journal,
25(40), Article 40.
https://doi.org/10.11604/pamj.2016.25.40.8329,
https://doi.org/10.11604/pamj.2016.25.40.8329
Leth, S., Nymann, R.
, Jorgensen, S., Olesen, R., Rasmussen, T. A., Østergaard, L. J., Denton, P. W., Tolstrup, M. & Sogaard, O. S. (2016).
HIV-1 transcriptional activity during frequent longitudinal sampling in aviremic patients on antiretroviral therapy.
AIDS,
30(5), 713-721.
https://doi.org/10.1097/QAD.0000000000000974
Moseholm, E., Helleberg, M., Nordly, S. B., Rosenfeldt, V.
, Storgaard, M., Pedersen, G., Johansen, I. S., Lunding, S., Weis, N. & Katzenstein, T. L. (2016).
Hospital admission among HIV-exposed uninfected children compared with HIV-unexposed children.
AIDS,
30(17), 2697-2706.
https://doi.org/10.1097/QAD.0000000000001230Faust, H.
, Nielsen, L. T., Sehr, P., Müller, M.
, Bonde, J., Forslund, O.
, Østergaard, L. J., Tolstrup, M. & Dillner, J. (2016).
Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines.
Vaccine,
34(13), 1559-1565.
https://doi.org/10.1016/j.vaccine.2016.02.019